Doctor profile · Federal record
Dr. Nazanin Saedi, M.D.
Dermatology Physician (CMS: Dermatology) · Internal Medicine Physician · Dermatology Physician · Philadelphia, PA
- NPI 1710178173
- Accepts Medicare
- 19 yrs in practice
- Licensed in 3 states
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
833 Chestnut St, Ste 740
Philadelphia, PA 191074414
(215) 955-6680
fax (215) 503-2556
Credentials & registration
- NPI registered
- August 2007 — 19 yrs on file
- Profile last updated
- April 19, 2017
- Year of graduation
- 2007 — 19 yrs since
- Specialty taxonomy
- 207N00000X — NUCC code
- State licenses (3)
- Pennsylvania #MD445744 · Massachusetts #232893 · Delaware #C1-0010161
- Medicaid (2)
- NJ #0308820 · PA #102737145
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1710178173. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
831
Distinct HCPCS
10
Medicare allowed
$103,063
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
17003 |
Destruction of precancer skin growth, 2-14 growths | 292 | 53 | $7 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 96 | 78 | $96 | |
17000 |
Destruction of precancer skin growth, 1 growth | 95 | 69 | $50 | |
17110 |
Destruction of skin growth, 1-14 growths | 82 | 65 | $121 | |
17311 |
Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks | 57 | 54 | $666 | |
11102 |
Biopsy of related skin growth, first growth | 54 | 47 | $88 | |
17312 |
Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks | 33 | 25 | $444 | |
13132 |
Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm | 28 | 27 | $291 | |
99212 |
Established patient office or other outpatient visit, 10-19 minutes | 27 | 24 | $60 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 26 | 26 | $119 |
In context: peer comparison
Among 55 peers in this city , average services per provider: 169. This provider delivers 4.9× the peer median.Open Payments
Industry payments received
All-time total
$15,853
Transactions
53
Manufacturers
14
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| ABBVIE INC. | 23 | $10,631.62 | |
| Galderma Laboratories, L.P. | 6 | $4,544.43 | |
| GENZYME CORPORATION | 3 | $202.39 | |
| Janssen Biotech, Inc. | 5 | $109.27 | |
| Amgen Inc. | 2 | $64.46 | |
| LEO Pharma Inc. | 3 | $61.17 | |
| Regeneron Healthcare Solutions, Inc. | 2 | $54.00 | |
| Lilly USA, LLC | 2 | $40.10 | |
| Paratek Pharmaceuticals, Inc. | 2 | $33.98 | |
| Incyte Corporation | 1 | $28.80 | |
| Dermavant Sciences, Inc. | 1 | $24.46 | |
| E.R. Squibb & Sons, L.L.C. | 1 | $21.24 | |
| Almirall LLC | 1 | $19.18 | |
| Arcutis Biotherapeutics, Inc. | 1 | $18.29 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
118
Patients
77
Total drug cost
$1,780
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Doxycycline Hyclate | Generic | 36 | 34 | $448 |
| Triamcinolone Acetonide | Generic | 30 | 21 | $369 |
| Ketoconazole | Generic | 27 | 11 | $389 |
| Clobetasol Propionate | Generic | 13 | 0 | $412 |
| Valacyclovir (Valacyclovir Hcl) | Brand | 12 | 11 | $161 |
Frequently asked questions
What is Dr. Nazanin Saedi's medical specialty?
Dr. Nazanin Saedi practices Dermatology Physician in Philadelphia, PA.
Where does Dr. Nazanin Saedi practice?
Dr. Nazanin Saedi practices at 833 Chestnut St, Philadelphia, PA 191074414. Office phone: 2159556680.
What is Dr. Nazanin Saedi's NPI?
Dr. Nazanin Saedi's National Provider Identifier (NPI) is 1710178173, issued by NPPES.
Does Dr. Nazanin Saedi accept Medicare assignment?
Yes. Dr. Nazanin Saedi accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Nazanin Saedi commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99213); Destruction of precancer skin growth, 1 growth (HCPCS 17000). Source: CMS Medicare Physician & Other Practitioners file.